Artra Group Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3121920007
JPY
143.00
6 (4.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
fureasu Co., Ltd.
Internet Infinity, Inc. (Japan)
TOWA Hi SYSTEM Co., Ltd.
Artra Group Corp.
DNA Chip Research, Inc.
Longlife Holding Co., Ltd.
I'rom Group Co., Ltd.
PLATZ Co., Ltd.
Uchiyama Holdings Co., Ltd.
Signpost Corp. (Tokyo)
Japan Tissue Engineering Co., Ltd.

Why is Artra Group Corp. ?

1
Poor Management Efficiency with a low ROCE of 1.24%
  • The company has been able to generate a Return on Capital Employed (avg) of 1.24% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.20
  • Poor long term growth as Operating profit has grown by an annual rate 16.83% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.20
  • The company has been able to generate a Return on Equity (avg) of 1.63% signifying low profitability per unit of shareholders funds
3
With a growth in Net Profit of 91.23%, the company declared Very Positive results in Dec 25
  • The company has declared positive results in Jan 70 after 3 consecutive negative quarters
  • ROCE(HY) Highest at 16.49%
  • RAW MATERIAL COST(Y) Fallen by -0.77% (YoY)
  • DEBT-EQUITY RATIO (HY) Lowest at -4.59 %
4
With ROE of 0.60%, it has a risky valuation with a 1.10 Price to Book Value
  • Over the past year, while the stock has generated a return of 8.33%, its profits have fallen by -92.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Artra Group Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Artra Group Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Artra Group Corp.
8.33%
-0.14
89.05%
Japan Nikkei 225
38.94%
1.38
28.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.18%
EBIT Growth (5y)
16.83%
EBIT to Interest (avg)
-12.20
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
1.54
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.24%
ROE (avg)
1.63%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
185
Industry P/E
Price to Book Value
1.10
EV to EBIT
139.50
EV to EBITDA
10.72
EV to Capital Employed
1.09
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.78%
ROE (Latest)
0.60%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
ROCE(HY)

Highest at 16.49%

RAW MATERIAL COST(Y)

Fallen by -0.77% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -4.59 %

NET PROFIT(Q)

At JPY 79.38 MM has Grown at 73.26%

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.26 times

Here's what is working for Artra Group Corp.

Net Profit
At JPY 79.38 MM has Grown at 73.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

Debt-Equity Ratio
Lowest at -4.59 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -0.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At JPY 26.73 MM has Grown at 26.43%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (JPY MM)

Here's what is not working for Artra Group Corp.

Debtors Turnover Ratio
Lowest at 5.26 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio